Pharmacology

Y. Chen, A. Mestek, J. Liu, J.A. Hurley, L. Yu, "Molecular cloning and functional expression of a f opioid receptor from rat brain," Molecular Pharmacology, 44:8-12, 1993. (Cited in 81 publications through December 1994) Comments by Lei Yu,Indiana University School of Medicine This description of the genetic sequence of the molecular receptor for "morphine-like drugs" marks the end of a 20-year quest, according to Lei Yu, a professor of medical and molecular genetics at the Indiana University

Written byNeeraja Sankaran
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Comments by Lei Yu,Indiana University School of Medicine

This description of the genetic sequence of the molecular receptor for "morphine-like drugs" marks the end of a 20-year quest, according to Lei Yu, a professor of medical and molecular genetics at the Indiana University School of Medicine.

"The pain-relieving properties of the poppy plant and opium from its juice have been known for several thousand years, and the opioids are still the most potent agents known to us," he remarks. Opioids include morphine, its synthetic analogs, as well as endorphins--analgesic substances produced by the body in response to such stress as pain. Named for morphine, the f receptor is the molecular target for these drugs. Determining the structure of the receptor or its gene would therefore "be a key step to understanding its function in pain relief," Yu says.

Based on information on a related receptor, his group became the first ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies